Clinical trial
Study of Medication and Placebo Response in Major Depression
NCT00229476 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00229476 |
|---|---|
| Title | Study of Medication and Placebo Response in Major Depression |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | Eli Lilly and Company Industry Pfizer Massachusetts General Hospital |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major |
| Intervention type | Drug |
| Interventions | sertraline (Zoloft) |
| Enrollment | 60 |
| Start date | Dec 1, 2003 |
| Primary completion | Mar 1, 2006 |
| First posted | Sep 29, 2005 |
| Last update posted | Nov 7, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: